| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |